Orphazyme gets another annual report extension approved

Biotech firm Orphazyme is pushing back the release of its annual report for 2021 once again, allowing the company to proceed with the ongoing in-court restructuring.
Photo: Orphazyme/PR
Photo: Orphazyme/PR
by marketwire, translated by daniel pedersen

Biotech company Orphazyme has been granted another new deadline for the release of its full-year 2021 report, the company has announced in a press release on Tuesday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading